Skip to main content
Clinical Trials/KCT0006866
KCT0006866Completed未知

Effect of age on 95% effective dose of remimazolam for loss of consciousness during anesthesia induction

Ajou University Hospital0 sites120 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational Study

Eligibility Criteria

Ages
20?(Year) to 79?(Year) (—)
Sex
All

Inclusion Criteria

  • Adult patients aged 20-79 who are scheduled to undergo general anesthesia

Exclusion Criteria

  • In the case of BMI > 30 kg/m2 or < 20 kg/m2, patients with contraindications such as allergies, hearing impairment, etc., making it difficult to respond to oral orders from researchers, and taking other drugs that may affect the effectiveness of benzodiazepine drugs.

Investigators

Sponsor
Ajou University Hospital

Similar Trials